Multiball Capital Research
Investment Thesis
Multiball Capital is a Los Angeles-based early-stage venture capital firm founded by Matt Kozlov, backing founders building the future of healthcare, aerospace & defense, and advanced manufacturing. The firm frames itself with a deliberately playful arcade/pinball motif ("Bump the Table", "Insert Coin", "Stage Select") wrapped around a serious thesis: physical, mission-critical technology in regulated or defense-adjacent sectors where deep technical founders can build durable, hard-to-replicate businesses. Kozlov's own public statements (via LinkedIn, cited in press coverage) describe a broader lens that also includes deep tech (robotics, aerospace, energy, AI/ML, edge computing), proptech, e-commerce/retail enablement, and B2B SaaS, though the firm's public-facing site narrows the story to three headline verticals.
Sector Focus
The three sectors called out explicitly on the firm's homepage are:
- Healthcare - portfolio includes MediCircle (reclaiming and redistributing high-value specialty medications) and TechNovaTime (AI-driven digital employees automating health-system workflows)
- Aerospace & Defense - the firm's largest and most visible bucket, spanning counter-drone systems, missile interceptors, satellite communications, defense logistics, and offensive cybersecurity for defense/intelligence use cases
- Advanced Manufacturing - represented by Aonics (autonomous ground robotics for solar farm inspection)
Within aerospace & defense specifically, the portfolio skews toward autonomy, robotics, and AI-enabled decision systems for military and intelligence customers rather than traditional primes or hardware manufacturing alone.
Stage Focus
Multiball invests at pre-seed and seed. Coverage of the firm's SEC filing (VCWire, July 2025) describes Kozlov as "investing in seed and pre-seed startups," consistent with Furientis's disclosed $5M pre-seed round, which Multiball participated in alongside Bessemer Venture Partners, Liquid 2, SV Angel, Silent Ventures, and Humba Ventures.
Check Size
No specific check-size range is publicly disclosed. Given a targeted $25M debut fund and syndicate participation (rather than sole-leading) in at least one disclosed round, checks are likely in the low hundreds-of-thousands range, but this is not confirmed and is intentionally omitted from structured fields rather than guessed.
Lead Tendency
Unknown/unconfirmed. The one disclosed round (Furientis) was a multi-investor syndicate that Multiball participated in rather than led.
Recent Activity
Multiball Capital Fund I, L.P. was disclosed via SEC filing in July 2025 with a $25M fundraising target (VCWire, July 11, 2025). As of the most recent public reporting, the fund had not yet formally closed. Despite this, the firm has been actively deploying: its site lists 12 portfolio companies, and one investment - Furientis, a defense-tech company building low-cost, high-volume anti-missile interceptor systems - was independently confirmed via a May 2026 $5M pre-seed announcement covering Multiball as a participating investor.
Portfolio Highlights
Twelve portfolio companies are listed on the firm's site, heavily weighted toward aerospace & defense:
- Furientis - low-cost, scalable anti-missile interceptors
- SplashOne Robotics - autonomous counter-drone systems
- VicoAI - event and geopolitical forecasting AI for defense, intelligence, and fintech
- Nebex - financing infrastructure for multi-national space projects
- Stat-Tis - real-time data for military logistics
- Autonomous Cyber - AI platform for offensive cybersecurity
- Soctera - power amplifiers for defense and communications
- Peregrine Space - gimbal-free laser optical communications for satellites
- Agentic Defense Solutions - trust infrastructure for AI deployed in military missions
- Aonics - autonomous ground robotics for solar farm inspection (advanced manufacturing)
- MediCircle - reclaiming and redistributing specialty medications (healthcare)
- TechNovaTime - AI digital employees for health systems (healthcare)
No exits are publicly disclosed to date; the firm and its portfolio are very early-stage.
Team
- Matt Kozlov, Managing Partner (Founder) - Roughly a decade as Managing Director across Techstars LA, Techstars Healthcare, and Techstars Space accelerators, working with roughly 200 portfolio companies including one decacorn, two unicorns, and 12+ companies valued over $100M. Prior operating roles include Head of Corporate Development at Telesign, CEO of mobile entertainment startup Moonshark, and product/strategy roles at Sony Music, Yahoo, and Bain & Company. He remains Managing Director Emeritus of Techstars LA, Techstars Healthcare, and Techstars Space.
The site also lists "Margaret," a black lab, as "Chief Morale Officer" - clearly a joke element of the firm's playful branding rather than an investment team member, and is excluded from structured team data.
Decision Process
Appears to be a solo-GP structure: Matt Kozlov is the only investment professional identified on the team page, with no additional partners or principals named publicly.
Founder Preferences
Given the portfolio composition, Multiball appears drawn to technical founders tackling capital-intensive, regulated, or defense-adjacent problems with a path to government or enterprise contracts - several portfolio companies (Furientis, SplashOne Robotics, Stat-Tis, Soctera, Peregrine Space) target defense and intelligence customers directly.
Geographic Focus
Based in Los Angeles, California. No explicit geographic restriction is stated on the site, and the portfolio does not indicate a strict regional focus.